• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Optimal Prescription of the Lower Dose of Apixaban.

作者信息

Eikelboom John, Wheeler Matt, Chan Noel

机构信息

Population Health Research Institute and Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada; McMaster University, Hamilton, Ontario, Canada.

Population Health Research Institute and Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada.

出版信息

J Am Coll Cardiol. 2020 Mar 17;75(10):1156-1158. doi: 10.1016/j.jacc.2019.12.061.

DOI:10.1016/j.jacc.2019.12.061
PMID:32164889
Abstract
摘要

相似文献

1
Optimal Prescription of the Lower Dose of Apixaban.
J Am Coll Cardiol. 2020 Mar 17;75(10):1156-1158. doi: 10.1016/j.jacc.2019.12.061.
2
Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.新型口服抗凝药物在房颤卒中预防中的应用：重点关注阿哌沙班。
Adv Ther. 2012 Jun;29(6):491-507. doi: 10.1007/s12325-012-0026-8. Epub 2012 Jun 7.
3
Apixaban for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: The PAROS cross-sectional study of routine clinical practice.法国非瓣膜性心房颤动患者中阿哌沙班预防卒中和全身性栓塞：PAROS 横断面研究常规临床实践。
Arch Cardiovasc Dis. 2019 Jun-Jul;112(6-7):400-409. doi: 10.1016/j.acvd.2019.02.003. Epub 2019 Apr 20.
4
Comparative effectiveness of warfarin, dabigatran, rivaroxaban and apixaban in non-valvular atrial fibrillation: A nationwide pharmacoepidemiological study.非瓣膜性心房颤动中华法林、达比加群、利伐沙班和阿哌沙班的疗效比较：一项全国范围的药物流行病学研究。
PLoS One. 2019 Aug 26;14(8):e0221500. doi: 10.1371/journal.pone.0221500. eCollection 2019.
5
Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial.在使用阿哌沙班或华法林抗凝治疗的房颤患者中，根据性别观察临床结局：一项随机对照试验的二次分析。
Eur Heart J. 2015 Dec 7;36(46):3268-75. doi: 10.1093/eurheartj/ehv447. Epub 2015 Sep 14.
6
Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with warfarin in the United States Medicare population.在美国医疗保险人群中，与华法林相比，起始使用阿哌沙班、达比加群或利伐沙班的非瓣膜性心房颤动患者发生中风/全身性栓塞、大出血及相关费用的风险。
Curr Med Res Opin. 2017 Sep;33(9):1595-1604. doi: 10.1080/03007995.2017.1345729. Epub 2017 Jul 11.
7
Risk of Recurrent Ischemic Stroke with Unintended Low-Dose Oral Anticoagulant Therapy and Optimal Timing of Review.非预期低剂量口服抗凝治疗复发性缺血性卒中的风险及最佳复查时机。
J Stroke Cerebrovasc Dis. 2018 Jun;27(6):1546-1551. doi: 10.1016/j.jstrokecerebrovasdis.2018.01.002. Epub 2018 Feb 1.
8
Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.真实世界中阿哌沙班在房颤卒中预防中的应用：系统评价和荟萃分析。
Stroke. 2018 Jan;49(1):98-106. doi: 10.1161/STROKEAHA.117.018395. Epub 2017 Nov 22.
9
Dabigatran, rivaroxaban and apixaban vs. high TTR warfarin in atrial fibrillation.达比加群、利伐沙班和阿哌沙班与房颤中高 TTR 的华法林比较。
Thromb Res. 2018 Jul;167:113-118. doi: 10.1016/j.thromres.2018.05.022. Epub 2018 May 17.
10
Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE Trial.阿哌沙班与华法林相比在心房颤动合并外周动脉疾病患者中的疗效和安全性：来自ARISTOTLE试验的见解
J Am Heart Assoc. 2017 Jan 17;6(1):e004699. doi: 10.1161/JAHA.116.004699.

引用本文的文献

1
Real-world apixaban concentration in Korean patients with atrial fibrillation.韩国房颤患者的真实世界阿哌沙班血药浓度
Blood Res. 2025 Jul 7;60(1):39. doi: 10.1007/s44313-025-00089-z.